PolyPeptide Group AG (PPGN) Price & Analysis

Compare

1 Followers

PPGN Stock Chart & Stats

CHF25.75

CHF1.30(6.77%)

At close: Mar 06 4:00 PM EST

CHF25.75

CHF1.30(6.77%)

Day’s Range― - ―

52-Week RangeCHF13.22 - CHF32.70

Previous CloseN/A

Volume22.87K

Average Volume (3M)34.07K

Market Cap

CHF822.48M

Enterprise ValueCHF956.60M

Total Cash (Recent Filing)CHF74.53M

Total Debt (Recent Filing)CHF130.46M

Price to Earnings (P/E)―

Beta1.14

Next Earnings

Aug 13, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.15

Shares Outstanding33,125,000

10 Day Avg. Volume33,840

30 Day Avg. Volume34,067

Financial Highlights & Ratios

PEG Ratio-5.12

Price to Book (P/B)2.72

Price to Sales (P/S)2.36

P/FCF Ratio-30.38

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

CHF35.50

Price Target Upside37.86% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)0.5

Revenue Forecast (FY)CHF475.13M

Bulls Say, Bears Say

Bulls Say

Consistent Revenue GrowthSustained revenue expansion, including mid-single-digit growth in 2025, indicates ongoing demand for peptide CDMO services and supports scale economics. Persistent top-line growth provides a durable foundation for margin recovery and reinvestment, improving medium-term commercial stability.

Improving Operating Cash FlowStronger operating cash flow shows the core CDMO operations generate cash even while accounting profits lag. Reliable OCF supports working-capital needs, funds incremental capacity investments, and underpins the company's ability to support customer projects without depending solely on external financing.

Specialized CDMO Business ModelA focused peptide CDMO with end-to-end development and GMP manufacturing creates high structural barriers to entry, deep technical expertise, and recurring commercial-supply opportunities. This specialization supports durable customer relationships and pricing power for complex peptide programs over time.

Bears Say

Ongoing Net LossesSustained net losses signal the company has not yet converted revenue growth into consistent profitability. Continued losses can erode equity, constrain reinvestment capacity, and require financing, making long-term margin recovery and sustainable return generation an execution risk for management.

Volatile Free Cash FlowSharp negative free cash flow in 2025 highlights uneven cash left after investment, likely from capex or working-capital swings. This volatility reduces financial flexibility, may force external funding during downturns, and complicates planning for capacity expansion tied to future contract wins.

Rising Leverage TrendIncreasing debt relative to equity weakens the balance sheet buffer and raises interest and refinancing risk. If profitability and free cash flow recovery lag, higher leverage could constrain strategic flexibility, elevate financing costs, and limit ability to pursue larger commercial-scale projects over the medium term.

PolyPeptide Group AG News

PolyPeptide expands EUR 200 million credit line to back growth and capacity plans

PolyPeptide Group AG ( ($CH:PPGN) ) has provided an announcement. PolyPeptide Group AG, a global CDMO specializing in...

1d ago

PolyPeptide Sets 2026 AGM to Confirm Board and Approve 2025 Reports

PolyPeptide Group AG ( ($CH:PPGN) ) has provided an announcement. PolyPeptide Group AG has published the invitation to...

3d ago

PolyPeptide lifts revenue and margins as peptide demand fuels major capacity build-out

PolyPeptide Group AG ( ($CH:PPGN) ) has issued an announcement. PolyPeptide Group reported 2025 revenue of EUR 389.3...

8d ago

PolyPeptide lifts revenue and margins in 2025 as GLP-1 demand powers growth

PolyPeptide Group AG ( ($CH:PPGN) ) just unveiled an update. PolyPeptide Group AG reported preliminary, unaudited results showing...

2M ago

PolyPeptide price target lowered to CHF 33 from CHF 35 at Barclays

Barclays lowered the firm’s price target on PolyPeptide (PLYGF) to CHF 33 from CHF 35 and keeps an...

2M ago

PolyPeptide and Lupin Forge Alliance to Boost Peptide Supply for Metabolic Therapies

PolyPeptide Group AG ( ($CH:PPGN) ) just unveiled an update. PolyPeptide Group AG has announced a strategic alliance...

3M ago

PolyPeptide Group Advances Malmö Facility Expansion

PolyPeptide Group AG ( ($CH:PPGN) ) just unveiled an update. PolyPeptide Group AG has reached a significant milestone...

6M ago

PolyPeptide Group Reports Strong First Half 2025 Growth and Raises Forecast

PolyPeptide Group AG ( ($CH:PPGN) ) has provided an update. PolyPeptide Group AG reported a 24% revenue growth...

7M ago

PolyPeptide Expands Credit Facility to Fuel Growth

The latest announcement is out from PolyPeptide Group AG ( ($CH:PPGN) ). PolyPeptide Group AG has expanded its...

10M ago

PolyPeptide Group AG’s Shareholders Approve Key Proposals at 2025 General Meeting

PolyPeptide Group AG ( ($CH:PPGN) ) has provided an update. At the fourth ordinary General Meeting, PolyPeptide Group...

11M ago

PPGN FAQ

What was PolyPeptide Group AG’s price range in the past 12 months?

PolyPeptide Group AG lowest stock price was CHF13.22 and its highest was CHF32.70 in the past 12 months.

What is PolyPeptide Group AG’s market cap?

PolyPeptide Group AG’s market cap is CHF822.48M.

When is PolyPeptide Group AG’s upcoming earnings report date?

PolyPeptide Group AG’s upcoming earnings report date is Aug 13, 2026 which is in 146 days.

How were PolyPeptide Group AG’s earnings last quarter?

PolyPeptide Group AG released its earnings results on Mar 12, 2026. The company reported CHF0.152 earnings per share for the quarter, missing the consensus estimate of CHF0.265 by -CHF0.113.

Is PolyPeptide Group AG overvalued?

According to Wall Street analysts PolyPeptide Group AG’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does PolyPeptide Group AG pay dividends?

PolyPeptide Group AG pays a Notavailable dividend of CHF0.3 which represents an annual dividend yield of N/A. See more information on PolyPeptide Group AG dividends here

What is PolyPeptide Group AG’s EPS estimate?

PolyPeptide Group AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does PolyPeptide Group AG have?

PolyPeptide Group AG has 33,125,000 shares outstanding.

What happened to PolyPeptide Group AG’s price movement after its last earnings report?

PolyPeptide Group AG reported an EPS of CHF0.152 in its last earnings report, missing expectations of CHF0.265. Following the earnings report the stock price went up 8.776%.

Which hedge fund is a major shareholder of PolyPeptide Group AG?

Currently, no hedge funds are holding shares in CH:PPGN

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

PolyPeptide Group AG

PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. It engages in manufacturing custom research grade peptides; and developing neoantigen peptide to support personalized cancer therapies. The company is also involved in manufacturing peptides for commercially approved peptide therapeutics. In addition, it manufactures peptide-based generics for human and veterinary markets; and cosmetic peptides. Further, the company offers regulatory affair support services. The company was founded in 1952 and is headquartered in Zug, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.

PolyPeptide Group AG (PPGN) Earnings & Revenues

Historic Earnings Reports

PPGN Stock 12 Month Forecast

Average Price Target

CHF35.50

▲(37.86% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"15":"CHF15","21":"CHF21","27":"CHF27","33":"CHF33","39":"CHF39"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF38.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF35.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF33.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[15,21,27,33,39],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.45,26.415384615384614,27.38076923076923,28.346153846153847,29.31153846153846,30.276923076923076,31.24230769230769,32.207692307692305,33.17307692307692,34.13846153846154,35.10384615384615,36.06923076923077,37.034615384615385,{"y":38,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.45,26.223076923076924,26.996153846153845,27.76923076923077,28.54230769230769,29.315384615384616,30.088461538461537,30.861538461538462,31.634615384615383,32.40769230769231,33.18076923076923,33.95384615384616,34.72692307692308,{"y":35.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.45,26.03076923076923,26.611538461538462,27.192307692307693,27.77307692307692,28.353846153846153,28.934615384615384,29.515384615384615,30.096153846153847,30.676923076923075,31.25769230769231,31.838461538461537,32.419230769230765,{"y":33,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":25.65,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.6,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.88,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.04,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.65,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.55,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.65,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.25,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.8,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":26.1,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":26.8,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":25.45,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 42, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >